| Table 1. Included studies | |||||
| Study | Country/Center | Enrolment Period | Embryos | Intervention | Control |
|---|---|---|---|---|---|
| Turkey, American Hospital of Istanbul | 2006.Jun to 2007.Feb | Fresh Blastocyst | N=193, Embryoglue (30 min) |
N=193, G2 + HSA | |
| Taiwan, IVF-Unit, Dr. Tsai & Dr. Chen’s Women Hospital | Unclear | Unclear | N=35, HSA + HA |
N=35, HSA |
|
| United Kingdom, TFP Oxford Fertility, Oxford | 2017 to 2019 | Fresh or frozen transfer of 1-2 cleavage stage embryos or blastocysts. |
N=343 Embryoglue (10-30min) |
N=338 COOK culture media |
|
| Chemnitz, Germany, Women’s Hospital, IVF, Basel, Switzerland, Fertilitas, IVF/ICSI Centre, Würzburg, Germany, University Hospital Würzburg, Dept. of Obstetrics and Gynecolgy |
2006.Jan to 2007.Mar | Fresh D3 embryos | N=54, EmbryoGlue (30min) |
N=48, G-1 and G-2 version 3 plus + 10% HSA |
|
| Unclear | Unclear | D3 or D5 embryos, single or double |
N=Unclear EmbryoGlue (10min) |
N=Unclear Standard media |
|
| Budapest, Hungary, Division of Assisted Reproduction, Semmelweis University |
2010.Jan to 2012.Aug | D2 ou D3, fresh embryos |
N=290, EmbryoGlue (10min) | N=291, G-2+ (Vitrolife) |
|
| Brussels, Belgium Hôpital Erasme, ULB, FIV Laboratoire |
2015.Jun to 2016.Jan | Day2/Day3 and Day5/Day6 |
N=136 Embryo-Glue |
N=192 Routine ET medium |
|
| Tel Aviv, Israel, IVF and Infertility Unit, Assaf Harofeh Medical Center Tel Aviv University | Unclear | D2 Embryos | N=94, Embryo-Glue |
N=93, HTF medium + 20% SSS |
|
| Israel, Assaf Harofeh Medical Center | 2005.Jun to 2006.Nov | D2 ou D3, fresh embryos |
N=51, EmbryoGlue |
N=50, HTF medium with gentamicin + 20% SSS |
|
| Elgin, IL, Sherman Hospital |
Unclear | D3 or D5 fresh embryos |
D3=85 D5=32 EmbryoGlue (10-60min) |
D3=79 D5=29 D3=IVC-1 or IVC-2 + 0.5% HSA D5= G2.3 + 0.5% HSA |
|
| Mumbai, India, Cellsure Biotech and Research Centre | 2017.Jan to 2018.Aug | Cleavage stage or blastocyst single fresh | N=153, EmbryoGlue | N=168, CSCM medium |
|
| Michigan, USA, IVF Michigan, Rochester Hills, IVF and Andrology Laboratory |
Unclear | D3 fresh embryos | N=Unclear EmbryoGlue (10min) |
N=Unclear P1 Complete medium |
|
| Ljubljana, Slovenia, Department of Obstetrics and Gynecology, University Medical Centre Ljubljana. Bregenz, Austria, Institute for Reproductive Medicine and Endocrinology, Roemerstrasse |
2004.Apr to 2006.Jun | Fresh and frozen single blastocyst transfer |
N=28 (fresh) N=102 (frozen) EmbryoGlue |
N=37 (fresh) N=112 (frozen) M2 medium |
|
| Yazd, Islamic Republic of Iran, Research and Clinical Centre for Infertilityin | 2003.Set to 2004.Jan | D3 Fresh embryos | N=30 EmbryoGlue (10min) |
N=30 Medium containing albumin 20% |
|
| Mayo Clinic, Rochester, Minnesota, USA |
2003.May to 2005.Jun | Frozen embryo transfers |
N=41 Embryoglue |
N=42 Standard medium |
|
| Israel, The Edith Wolfson Medical center |
2004.Jul to 2004.Nov | Fresh embryo transfers |
N=79 EmbryoGlue (10min) |
N=69 Medium G-1 |
|
| Englewood, Colorado; Colorado Ctr for Reproductive Medicine | 2001.Jan to 2002.Feb | D3 fresh embryos | N=91 EmbryoGlue |
N=84 Medium G2 |
|
| Alicante, Spain, Department of Reproductive Medicine, Instituto Bernabeu | 2018.Mar to 2019.Jan | D5 Fresh single embryo transfer |
N=48 (first randomization) EmbryoGlue |
N=61 (first randomization) Global Total (GT)®, LifeGlobal® |
|
| Alicante, Spain, Department of Reproductive Medicine, Instituto Bernabeu | 2018.Mar to 2019.Jan |
D5 Fresh single embryo transfer |
N=104 (second randomization) EmbryoGlue |
N=89 (second randomization) Continuous Single Culture® Complete (CSCC) |
|
| Jerusalem, Israel, IVF unit, Departament of
Obstretics and Gynecology, Hadassah University Hospital Ein Kerem |
Unclear | D3 Fresh embryos | N=40, P1 medium supplemented with 0.5 mg/ml of highly purified fermentation-based hyaluronic acid (5-10min) |
N=40, P1 Medium containing 10%of SSS |
|
| Istanbul, Turkey, Assisted Reproduction Unit, American Hospital of Istanbul |
2006.Jun and 2007.Feb | D3 or D5 fresh embryos |
D3=412 D5=227 EmbryoGlue (30min) |
D3=413 D5=230 G2, version 3 + HSA |
|
| Rochester, MN, Mayo Clinic College of
Medicine, London, United Kingdom, London Fertility Centre |
Unclear | Frozen clevage embryo transfer |
N=34 EmbryoGlue® |
N=34 G1.3 media |
|
| Istanbul, Turkey, VKV American Hospital, Assisted Reproduction Unit |
Unclear | Frozen-thawed embryo |
N=65, EmbryoGlue |
N=64, G2 culture medium |
|
| Hong Kong The Centre of Assisted Reproduction and Embryology, The University of Hong Kong -Queen Mary Hospital, The Dr. Stephen Chow Chun-kay Assisted Reproduction Centre, Kwong Wah Hospital |
2016. Apr to 2018.Apr | Frozen Cleavage stage embryos or blastocysts |
N=275 EmbryoGlue |
N=275 G-2 medium (Vitrolife) |
|
HSA=Human serum albumin solution; HA=Hyaluronic Acid; IVC=In VitroCare; SSS= Synthetic serum substitute; HTF=human tubal fluid